A detailed history of Janus Henderson Group PLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 168,500 shares of HRMY stock, worth $5.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
168,500
Previous 178,367 5.53%
Holding current value
$5.53 Million
Previous $5.38 Million 25.09%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.0 - $39.95 $296,010 - $394,186
-9,867 Reduced 5.53%
168,500 $6.73 Million
Q2 2024

Aug 14, 2024

SELL
$28.81 - $33.01 $193,487 - $221,695
-6,716 Reduced 3.63%
178,367 $5.38 Million
Q1 2024

May 15, 2024

BUY
$29.93 - $35.06 $5.04 Million - $5.91 Million
168,434 Added 1011.68%
185,083 $6.22 Million
Q4 2023

Feb 14, 2024

SELL
$19.2 - $33.78 $787 - $1,384
-41 Reduced 0.25%
16,649 $537,000
Q3 2023

Nov 14, 2023

BUY
$31.89 - $39.03 $127 - $156
4 Added 0.02%
16,690 $546,000
Q2 2023

Aug 14, 2023

SELL
$30.5 - $37.4 $1.06 Million - $1.3 Million
-34,691 Reduced 67.52%
16,686 $587,000
Q1 2023

May 15, 2023

SELL
$30.8 - $53.92 $38.2 Million - $66.9 Million
-1,240,758 Reduced 96.02%
51,377 $1.68 Million
Q4 2022

Feb 14, 2023

SELL
$45.4 - $60.91 $10.1 Million - $13.6 Million
-222,968 Reduced 14.72%
1,292,135 $71.2 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $3.78 Million - $4.99 Million
89,935 Added 6.31%
1,515,103 $67.1 Million
Q2 2022

Aug 15, 2022

SELL
$33.54 - $52.15 $6.03 Million - $9.37 Million
-179,741 Reduced 11.2%
1,425,168 $69.5 Million
Q1 2022

May 16, 2022

BUY
$33.14 - $51.13 $2.03 Million - $3.13 Million
61,185 Added 3.96%
1,604,909 $78.1 Million
Q4 2021

Feb 14, 2022

BUY
$34.09 - $43.91 $11.1 Million - $14.2 Million
324,165 Added 26.58%
1,543,724 $65.8 Million
Q3 2021

Nov 16, 2021

SELL
$25.68 - $38.61 $1.07 Million - $1.62 Million
-41,833 Reduced 3.32%
1,219,559 $46.7 Million
Q2 2021

Aug 16, 2021

BUY
$25.96 - $33.44 $2.79 Million - $3.6 Million
107,609 Added 9.33%
1,261,392 $35.6 Million
Q1 2021

May 17, 2021

BUY
$27.56 - $40.37 $1.64 Million - $2.4 Million
59,334 Added 5.42%
1,153,783 $38.1 Million
Q4 2020

Feb 16, 2021

BUY
$31.74 - $51.34 $6.97 Million - $11.3 Million
219,540 Added 25.09%
1,094,449 $39.6 Million
Q3 2020

Nov 16, 2020

BUY
$30.96 - $44.39 $27.1 Million - $38.8 Million
874,909 New
874,909 $29.7 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.94B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.